Biotech pain con­tin­ues as Ver­sant, MPM gene ther­a­py start­up calls it quits

A gene ther­a­py start­up backed by two key bio­phar­mas and two pre­mier biotech VC firms has ceased op­er­a­tions.

Cal­i­for­nia biotech Co­da Bio­ther­a­peu­tics shut down re­cent­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER